Many people are not aware of the contribution that pharmaceutical companies make to human welfare. Not only do their medicines save lives, improve health, and prolong and enhance the quality of life, but medicines also reduce overall healthcare costs by speeding up recovery times. Often they reduce the need for surgery and hospitalisation.
Today’s new medicines often result in better adherence and compliance due to simpler dosage regimens, improved delivery systems and fewer side-eﬀects. Nowadays the harmful consequences of many diseases – like amputation in diabetes and strokes or heart attacks as a result of high blood pressure or cholesterol – can be prevented. Historically deadly diseases like smallpox, polio, diabetes, asthma, heart attacks, TB and malaria can now be treated successfully.
Although much progress has been made in developing new medicines in the last few decades, innovation remains an essential component of the global healthcare industry. Unmet medical needs, the emergence of new infectious diseases and the “super bugs” that are produced by increasing resistance to existing treatments bring new challenges every day. IPASA believes it is critical to continually garner the commitment and support of all our pharmaceutical stakeholders, and to establish eﬀective networks and partnerships that will continue to boost innovation, improve treatment and save lives. As a member of the International Federation Of Pharmaceutical Manufacturers & Associations (IFPMA), IPASA and its members uphold the research and development of safe, high-quality and eﬀective disease treatments that improve patients’ health. This work includes the development of innovative drugs and vaccines, the support for programmes of research and development for diseases prevailing in developing countries, and research into paediatric medicines. South Africa’s pharmaceutical industry does more than provide health-promoting medicines to South Africans. It also makes a substantial contribution to the region by investing in local healthcare and ensuring continued access to new medicines. In addition, pharmaceutical companies stimulate the local economy through employment, taxes, skills development and technology transfer.
An overarching ethic of IPASA members is that they conduct business in a socially responsible and friendly manner – in the South African spirit of Ubuntu – and they help communities through numerous social investment programmes.